Bio-Rad’s New SsoFast Probes Supermix Accelerates Gene Expression Analysis
Publication date: 12 October 2010
Author: Bio-Rad
Tagged with: Bio-Rad, qPCR, Viresh Patel
Bio-Rad’s recently introduced SsoFast™ probes supermix is a reagent that enables researchers using fluorogenic probes to enhance the speed, reliability, and sensitivity of their qPCR experiments.
By combining Bio-Rad’s patented Sso7d fusion polymerase with an optimized buffer formulation, the SsoFast probes supermix yields fast duplex qPCR results in 30 minutes or less compared to other similar products that require 40 minutes or more. SsoFast probes supermix pushes the limits of fast qPCR, while maintaining a broad dynamic range of detection, reliability, and accurate quantification. Furthermore, this polymerase is significantly more resistant to PCR inhibitors, making SsoFast probes supermix an ideal choice for demanding qPCR applications.
“Bio-Rad’s hot-start Sso7d-fusion polymerase enables our PCR reagents to address researchers’ constant need for faster time-to-results,” said Viresh Patel, Marketing Manager, PCR Reagents. “The SsoFast probes supermix provides researchers using fluorogenic probes for gene expression analysis the fast results they seek.”
Researchers can incorporate the SsoFast probes supermix effortlessly in their real-time PCR experiments. The supermix is fully compatible with universal cycling conditions and a wide range of primer/probe concentrations without requiring additional optimization. It can also be used on both fast and standard cycling instruments without protocol changes.
The performance of SsoFast probes supermix is enhanced when used with Bio-Rad’s CFX96 or CFX384 Real-Time PCR Systems. The thermal uniformity and detection capabilities of the instrument take full advantage of the supermix’s fast polymerase and optimized formulation to deliver fast, reproducible qPCR results.
For more information about Bio-Rad’s family of SsoFast PCR reagents, visit www.bio-rad.com/supermixes.
Advertisement:
Email newsletter
If you enjoyed this article sign-up to receive our bi-weekly email newsletter:
Latest news
- Fast plasma sample cleanup with new Phree Phospholipid Removal Plates (21 May 2012)
- Two overall winners announced at prestigious national award ceremony in London’s Science Museum (18 May 2012)
- New analysis of risk stratification for TYSABRI® published in New England Journal of Medicine (18 May 2012)
- NUCYNTA® ER (tapentadol) tablets provide pain management for patients with Diabetic Peripheral Neuropathy (DPN) (18 May 2012)
- GSK statement on tender offer to acquire Human Genome Sciences (18 May 2012)
In-depth focus:
Mass Spectrometry
This free to view Mass Spectrometry in-depth focus is sponsored by Waters, Bruker, Protea and Dr. Hochmuth and contains the following articles:
- Mass spectrometry in drug discovery - Proteomics, small molecules and metablomics
- Quantification of membrane drug transporters and application in drug discovery and development
- Anthony Bristow, AstraZeneca, poses the questions for our Mass Spectrometry Leaders Roundtable
Company directory
ABB Analytical Measurements | Almac | B&W Tek, Inc. | BASF | BD Diagnostics | Bio-Optronics, Inc. | bioMérieux | BioTek Instruments, Inc. | Bruker Optics | CAMO Software AS | Catalent Pharma Solutions | Chemspec Europe Ltd | CI Precision | Cisbio Bioassays | EMD Millipore | GE Analytical Instruments | Gerresheimer Group | HACH LANGE GMBH | HORIBA Scientific | I Holland Limited | Lonza | Merck Millipore | Pall Life Sciences | Patheon Inc | Phenomenex | Porvair Sciences Ltd | Randox Pharma Services | Rapid Micro Biosystems | Realia | Roche | rommelag® | Umetrics |
Login to access exclusive content